238 related articles for article (PubMed ID: 3100940)
1. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
Hess EJ; Battaglia G; Norman AB; Creese I
Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on [3H]SCH23390 and [3H]forskolin binding in rat striatum.
Norman AB; Wachendorf TJ; Sanberg PR
Life Sci; 1989; 44(13):831-6. PubMed ID: 2648096
[TBL] [Abstract][Full Text] [Related]
3. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
Roseboom PH; Gnegy ME
Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
5. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
Yocca FD; Iben L; Meller E
Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
[TBL] [Abstract][Full Text] [Related]
6. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
7. In vivo partial inactivation of dopamine D1 receptors induces hypersensitivity of cortical dopamine-sensitive adenylate cyclase: permissive role of alpha 1-adrenergic receptors.
Trovero F; Hervé D; Blanc G; Glowinski J; Tassin JP
J Neurochem; 1992 Jul; 59(1):331-7. PubMed ID: 1351927
[TBL] [Abstract][Full Text] [Related]
8. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Onali P; Olianas MC; Gessa GL
Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
[TBL] [Abstract][Full Text] [Related]
9. Functional recovery of D1 dopamine receptor-mediated stimulation of rat striatal adenylate cyclase activity following irreversible receptor modification by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): evidence for spare receptors.
Battaglia G; Norman AB; Hess EJ; Creese I
Neurosci Lett; 1986 Sep; 69(3):290-5. PubMed ID: 2945128
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
Morissette M; Lévesque D; Di Paolo T
Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544
[TBL] [Abstract][Full Text] [Related]
11. Agonist-induced desensitization of D1-dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells.
Barton AC; Sibley DR
Mol Pharmacol; 1990 Oct; 38(4):531-41. PubMed ID: 1978240
[TBL] [Abstract][Full Text] [Related]
12. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
Lévesque D; Di Paolo T
Mol Pharmacol; 1991 May; 39(5):659-65. PubMed ID: 1674586
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic behaviors and signal transduction mediated through adenylate cyclase and phospholipase C pathways.
Undie AS; Berki AC; Beardsley K
Neuropharmacology; 2000; 39(1):75-87. PubMed ID: 10665821
[TBL] [Abstract][Full Text] [Related]
14. Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors.
Hess EJ; Norman AB; Creese I
J Neurosci; 1988 Jul; 8(7):2361-70. PubMed ID: 2907912
[TBL] [Abstract][Full Text] [Related]
15. Spare receptors and intrinsic activity: studies with D1 dopamine receptor agonists.
Watts VJ; Lawler CP; Gonzales AJ; Zhou QY; Civelli O; Nichols DE; Mailman RB
Synapse; 1995 Oct; 21(2):177-87. PubMed ID: 8584979
[TBL] [Abstract][Full Text] [Related]
16. Castration blocks chronic sulpiride-induced desensitization of striatal D1 receptor-stimulated adenylate cyclase activity in male rats.
Ryan-Jastrow T; Gnegy ME
J Pharmacol Exp Ther; 1989 Feb; 248(2):626-31. PubMed ID: 2521900
[TBL] [Abstract][Full Text] [Related]
17. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
Cooper DM; Bier-Laning CM; Halford MK; Ahlijanian MK; Zahniser NR
Mol Pharmacol; 1986 Feb; 29(2):113-9. PubMed ID: 3005824
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.
Meller E; Bohmaker K; Goldstein M; Friedhoff AJ
J Pharmacol Exp Ther; 1985 Jun; 233(3):656-62. PubMed ID: 2861276
[TBL] [Abstract][Full Text] [Related]
19. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
Burger LY; Martin-Iverson MT
Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
[TBL] [Abstract][Full Text] [Related]
20. Effect of cholera toxin on the activation of adenylate cyclase by calmodulin in bovine striatum.
Mickevicius CK; Harrison JK; Gnegy ME
Mol Pharmacol; 1986 Nov; 30(5):469-75. PubMed ID: 3773884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
